Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toll-like Receptor 9 Enhancement of Antiviral Immunity in Chronic HIV-1 Infection: a Phase 1b/2a Trial

NCT02443935 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.

NCT NCT02443935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02443935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toll-like Receptor 9 Enhancement of Antiviral Immunity in Chronic HIV-1 Infection: a Phase 1b/2a Trial
Lead sponsor
University of Aarhus
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2015
Completion date
June 25, 2017
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv